Using an opioid to treat opioid addiction can sound like a contradiction, but the science tells a different story and it saves lives. I’m joined by Dr. Julia D’Alo from GRC’s Advanced Recovery Network to explain, in plain language, what medications for substance use disorders are and why medications for opioid use disorder (MOUD) are considered the gold standard for care.

We walk through the three FDA-approved options for opioid use disorder treatment: methadone, buprenorphine, and naltrexone. You’ll hear how buprenorphine works as a partial agonist, why that “partial” effect can make it safer, and how it relieves opioid withdrawal symptoms and cravings so people can stop waking up consumed by the next dose. We also talk about methadone as a full agonist, why it can be highly effective with the right monitoring, and how naltrexone works as a blocker, including the tradeoff that it may not ease cravings or the “sick” feeling of withdrawal for everyone.

We also tackle the stigma head-on: the misconception that medication is “just replacing one drug with another,” the reality of physical dependence, and how people can taper safely when it’s appropriate. Most importantly, we connect MOUD to real outcomes that matter: better treatment retention, less illicit opioid use, lower fatal overdose risk, fewer infections like HIV and hepatitis, and more stability at work and at home. If you’re in southwestern Pennsylvania, GRC’s Advanced Recovery Network offers a full continuum of care across 16 locations plus statewide telehealth services.

Subscribe so you don’t miss future conversations, share this with someone who needs a clearer picture of MAT and MOUD, and leave a review with your biggest takeaway.

To learn more about GRC’s Advanced Recovery Network visit:
https://www.GatewayRehab.org
GRC’s Advanced Recovery Network
Multiple Southwestern Pennsylvania Locations
800-472-1177